Documents

A short description of the experiments conducted to decide on HepG2 cells as the appropriate line for the generation of an MCAD knockout. IHH, Hep3B, HepG2, and HUH-7 cells were all consdered.

This survey is organized by WG1 (Compound libraries coordination and integration of compound design) of COST Action CA21111 "OneHealthDrugs" and collects information from COST Action members about the handling of chemical compound information and the usage of compound databases/repositories. The results will help to coordinate and integrate compound data from different resources for searching and screening purposes by the COST Action participants.

This contains the final version of my thesis as well as the implemented figures as .pgf and .svg files.

Figures showing the changes of edges and terms.

This document is associated with metadata file and describes compounds used in this study.

Program of COMBINE sessions on 6th, 7th Oct. 2022 and COMBINE Forum on 8th Oct. 2022.

Prov-O Representation for an enrichment analysis experiment on differentially expressed RNA-Seq data, analysed with Enrichr and 2021 version of GO. Rectangle represents Activity, eclipse represents entity and rhombus represents agents

Bericht über die neuesten Aktiväten des Brustkrebsforschungsprojektes MESI-STRAT

Neuigkeiten aus dem MESI-STRAT Projekt und Konsortium

steatosis pattern analysis report using Histokat, a proprietary software based on a machine-learning algorithm created by Fraunhofer MEVIS

Steatosis Quantification (Lipid droplet analysis) report using Histokat, a proprietary software based on a machine-learning algorithm created by Fraunhofer MEVIS

Raw data used for Steatosis and CYP quantification and TG, PK-data, AUC, t-halflife and C-max

Excel file involves all experiment data including feeding plan, sampling plan, and the Pharmacokinetic data results

Supplementary table containing all reactions, genes, and metabolites involved in the metabolic model iAA835 .

News about the MESI-STRAT project and consortium

_p_SUSPHIRE/_I_T21_SXPsysbio/_S_P4_SxP12-newG-DE/_A_03_SxPv12_limmavoom_DE-R/

_p_SUSPHIRE/_I_T21_SXPsysbio/_S_P4_SxP12-newG-DE/_A_03_SxPv12_limmavoom_DE-R/

_p_SUSPHIRE/_I_T21_SXPsysbio/_S_P4_SxP12-newG-DE/_A_04_SxPv12_GeneSetEnrichment-RNAseg-GSEA/

_p_SUSPHIRE/_I_T21_SXPsysbio/_S_P4_SxP12-newG-DE/_A_04_SxPv12_GeneSetEnrichment-RNAseg-GSEA/

_p_SUSPHIRE/_I_T21_SXPsysbio/_S_P4_SxP12-newG-DE/_A_02_SxPv12_mapping-CLC/

_p_SUSPHIRE/_I_T21_SXPsysbio/_S_P4_SxP12-newG-DE/_A_04_SxPv12_GeneSetEnrichment-RNAseg-GSEA/

_p_SUSPHIRE/_I_T21_SXPsysbio/_S_P4_SxP12-newG-DE/_A_04_SxPv12_GeneSetEnrichment-RNAseg-GSEA/

_p_SUSPHIRE/_I_T21_SXPsysbio/_S_P4_SxP12-newG-DE/_A_01_SxPv12_fastq-QC/

_p_SUSPHIRE/_I_T21_SXPsysbio/_S_P4_SxP12-newG-DE/_A_01_SxPv12_fastq-QC/